During the past decade, Hospital Aleman conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 7 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 7 clinical trials were completed. i.e. 30.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Aleman" #1 sponsor was "Janssen Research & Development, LLC" with 9 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Hospital Aleman" with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Aleman" #1 collaborator was "NSABP Foundation Inc" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chiba University, Japan" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Aleman" are "Prostatic Neoplasms" (4 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Chronic Hepatitis" (2 trials), "Hepatitis B" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Hospital Aleman" in a lesser frequency.

Most popular intervention types in "Hospital Aleman" are "Drug" (32 trials), "Other" (5 trials), "Biological" (4 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Dexamethasone" (4 trials), "Pembrolizumab" (4 trials), "Prednisone" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Aleman" are 34 trials for "All" genders, 7 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Aleman". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Hospital Aleman, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Aleman, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".